On 22 and 23 November, Fortis Memorial Research Institute, Gurugram (Fortis Gurugram) hosted HemeNext 1.0, a pioneering national conference exploring how genomics, artificial intelligence, robotics and advanced cell therapies are reshaping haematology and infectious disease care across India.
With the nation facing rising cases of blood cancers, immune disorders and complex infections, the two-day event emphasised the growing importance of early diagnosis and personalised, data-driven treatment. More than 150 clinicians attended in person, while over 1,700 participants joined online, including haematologists, infectious disease specialists, bone marrow transplant physicians, CAR-T innovators and young clinicians.
A major highlight was India’s first humanoid healthcare host, Hembot. Powered by NVIDIA Jetson Orin, the robot greeted delegates, guided them to sessions, engaged in discussions and even joined the gala evening. Its presence demonstrated how future hospitals may use humanoid robotics for patient navigation, clinical support, monitoring assistance and uplifting the overall care experience.
The conference’s scientific discussions centred on the growing impact of genomics in diagnosing and treating leukaemia, lymphoma, bone marrow failure syndromes and inherited blood disorders. Experts highlighted advances such as next-generation sequencing for deep cancer profiling, mutation analysis for sharper diagnoses, relapse prediction through genomic algorithms and genomics-based donor matching that improves transplant safety and success.
HemeNext 1.0 also showcased how AI, robotics and next-generation therapies like CAR-T are enabling faster diagnoses, more accurate testing, safer bone marrow transplants and better survival outcomes through personalised treatment pathways. Real-world case discussions and mentorship sessions reinforced how these innovations are improving everyday clinical decisions.
Leaders from Fortis Gurugram shared their commitment to building one of India’s strongest precision-haematology ecosystems, uniting genomics, advanced diagnostics, cell therapies and AI-driven tools to provide comprehensive care for adults and children alike.
HemeNext 1.0 reflects Fortis Gurugram’s vision for compassionate, technology-enabled haematology care that brings renewed hope to patients across India.
Related Stories
Gleneagles Hong Kong to Launch Groundbreaking Longevity Service
Gleneagles Hong Kong is set to transform preventive care as the city’s first hospital network to offer a groundbreaking AI-powered longevity service.
Fortis Leads the Way in Building a Nation of First Responders
When a cardiac emergency strikes, survival often depends on what happens in the first few minutes. Before an ambulance arrives. Before hospital doors open. In those moments, a trained bystander can mean the difference between life and loss.
Gleneagles JPMC Collects 418kg of Waste in Beach Clean-Up Effort
Celebrate our Brunei colleagues for stepping beyond the hospital walls to make a real, measurable impact on the environment.
.png?sfvrsn=36e1af94_1)
Fortis Hospital Bannerghatta Road Successfully Treats Rare Nasal Tumour in Teen
After nearly two years of misdiagnosis, a 14-year-old boy suffering from a rare nasal tumour found a new lease of life at Fortis Hospital Bannerghatta Road.
Mount Elizabeth’s Revitalisation Sets a New Benchmark for Patient-Centred Care in the Region
IHH Healthcare Singapore is strengthening its legacy of care through the revitalisation of Mount Elizabeth Hospital (MEH), a flagship institution that has supported patients from Singapore, Indonesia and across the region for more than 45 years.
Proudly the First: IHH Healthcare Singapore Achieves Full National Electronic Health Record Participation
IHH is proud to be the first private healthcare group in Singapore with all four hospitals fully contributing to the National Electronic Health Record (NEHR), reflecting our steadfast commitment to advancing continuity of care and building a more connected, patient-centred healthcare ecosystem.
